| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Interim CEO | President and CEO
2 companies
Richard A Barasch last filed a Form 4 in July 2025, as Director at TOI. The filings on record cover 2 companies. Richard A Barasch's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
Historically, Richard A Barasch's trades have earned a middling insider score of 56/100 across 5 rated trades. Over a 12-month horizon, 40.0% of those trades were profitable, with an average 12-month return of -6.5%.
At the last filing, the largest reported position was 438,355 shares of AHCO.
Richard A Barasch has 30 Form 4 filings on record from February 2018 to July 2025, across 2 companies: Director at Oncology Institute (TOI), 2021–2025; Director at AdaptHealth (AHCO), 2018–2024.
The 55 reported transactions were 17 open-market purchases, 15 stock awards, 12 other transactions and 6 tax withholdings, plus smaller numbers of other types.
Counted by filing, the open-market trades come to 5 purchases worth about $1.5M and no sales.
The largest open-market purchase was 1,358,448 shares of TOI at an average $1.04 on March 26, 2025, about $1.4M. Twelve months later TOI was up 156%.
Shares as reported in the last Form 4 for each company; the most recent is from July 2025. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 26, 2025 | TOI Oncology Institute, Inc. | Director | Buy | 1,358,448 | $1.04 | $1,415,095.28 | +325.6% | +94.2% | +156.2% | |
| Mar 17, 2023 | TOI Oncology Institute, Inc. | Director | Buy | 50,000 | $0.55 | $27,495.26 | +24.1% | +25.9% | +249.3% | |
| Nov 24, 2021 | TOI Oncology Institute, Inc. | Director | Buy | 5,000 | $6.92 | $34,604.64 | +5.5% | -10.5% | -78.1% | |
| Nov 23, 2021 | TOI Oncology Institute, Inc. | Director | Buy | 5,000 | $6.34 | $31,699.35 | +5.8% | -3.6% | -76.2% | |
| Nov 16, 2021 | TOI Oncology Institute, Inc. | Director | Buy | 1,000 | $10.12 | $10,115.00 | +1.2% | -26.3% | -78.0% |